- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02475018
The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human
June 16, 2015 updated by: Inner Mongolia Yili Industrial Group Co., Ltd
The purpose of this study is to determine whether YiLi Xinhuo Shuhua Milk is effective in reducing the serum cholesterol in human with hypercholesterolemia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In a randomized, placebo-controlled double-blind mono-centric study,179 subjects with total cholesterol (TC) level above 5.18mmol/L and triglyceride (TG) level lower than 2.25mmol/L were assigned to 500ml of low lactose milk enriched with 1.58g plant sterol esters or 500ml plain milk without plant sterols (placebo) or without any dairy product consumption (control) for 60 days.
Subjects were instructed to maintain stable diet pattern and physical activity.
Plasma concentrations of TC,TG,LDL cholesterol(LDL-C) and HDL cholesterol(HDL-C) were measured at initial visits, after 30days and after 60 days.
The primary measurement was the change in TC.
Secondary measurements were changes in TG,LDL-C and HDL-C.
Study Type
Interventional
Enrollment (Actual)
179
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100053
- BaiZhiFang Community Health Service Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female subjects, 18-65 yrs;
- Serum TC ≥5.18mmol/L, and TG≤2.25mmol/L;
- Normal blood pressure or able to control blood pressure within normal range;
- Willing to consent to study participation and to comply with study requirements.
Exclusion Criteria:
- Pregnant or breastfeeding women;
- Known allergies to dairy and any substance in the study product.For example lactose intolerance;
- Any comorbidity that could,in the opinion of the investigator, preclude the subject's ability to successfully and safely complete the study or that may confound study outcomes, including but not limited to cardiac disease, hepatic disease, renal disease, hematopoietic system disease and mental disease;
- Recent use (within 2 weeks of screening) of any prescription or OTC medication that affects serum total cholesterol or that may confound study outcomes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Milk fortified with plant sterol esters
250mL of Shuhua Milk fortified with plant sterol esters(with plant sterol esters 262mg/100mL) has been taken twice per day.
500mL of Shuhua milk in total has been taken per day during the 60-days intervention.
|
250mL of Shuhua milk fortified with plant sterol esters(with plant sterol esters 262mg/100mL) has been taken twice per day.
500mL of Shuhua milk in total has been taken per day during the 60-days intervention.
|
Placebo Comparator: Plain milk
250mL of placebo milk(plain milk) has been taken twice per day.
500mL of plain milk in total has been taken per day during the 60-days intervention.
|
250mL of placebo milk (plain milk) has been taken twice per day.
500mL of plain milk in total has been taken per day during the 60-days intervention.
|
No Intervention: No dairy product consumption
Participants have not consumed any dairy product during the 60-days of study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Total Cholesterol(TC) during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
|
Baseline & 1 months & 2 mongths
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Triglyceride(TG) during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
|
Baseline & 1 months & 2 mongths
|
Change in LDL-C level during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
|
Baseline & 1 months & 2 mongths
|
Change in HDL-C level during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
|
Baseline & 1 months & 2 mongths
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ignatious Szeto, Ph.D, Inner Mongolia Yili Industrial Group Co., Ltd
- Principal Investigator: Jing Zhu, Beijing Research Institute for Nutrition Resources
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
June 16, 2015
First Submitted That Met QC Criteria
June 16, 2015
First Posted (Estimate)
June 18, 2015
Study Record Updates
Last Update Posted (Estimate)
June 18, 2015
Last Update Submitted That Met QC Criteria
June 16, 2015
Last Verified
July 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YL/CL-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineUnknownPrimary HypercholesterolemiaUnited States
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Merck Sharp & Dohme LLCTerminated
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
Clinical Trials on Milk fortified with plant sterol esters
-
University Hospital, SaarlandUnknown
-
The George InstitutePeking UniversityCompleted
-
University of ManitobaWhiteWave Foods, Inc.Completed
-
NestléFood and Nutrition Research Institute, Philippines; ETH Zurich (Switzerland)Completed
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone SpainCompletedHypercholesterolemiaSpain
-
Danone ResearchCompletedHypercholesterolemiaUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan